AGT and Alzheimer disease: The pooled estimate showed that Ang-II stimulating AHMs reduced the risk of AD by 12% compared to Ang-II inhibiting AHMs (HR = 0.88, 95% CI = 0.86–0.90, p < 0.01) (Fig. S9).